Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.
Earnest R, Uddin R, Matluk N, Renzette N, Siddle KJ, Loreth C, Adams G, Tomkins-Tinch CH, Petrone ME, Rothman JE, Breban MI, Koch RT, Billig K, Fauver JR, Vogels CBF, Turbett S, Bilguvar K, De Kumar B, Landry ML, Peaper DR, Kelly K, Omerza G, Grieser H, Meak S, Martha J, Dewey HH, Kales S, Berenzy D, Carpenter-Azevedo K, King E, Huard RC, Smole SC, Brown CM, Fink T, Lang AS, Gallagher GR, Sabeti PC, Gabriel S, MacInnis BL; New England Variant Investigation Team; Tewhey R, Adams MD, Park DJ, Lemieux JE, Grubaugh ND. Earnest R, et al. Among authors: uddin r. medRxiv [Preprint]. 2021 Oct 7:2021.10.06.21264641. doi: 10.1101/2021.10.06.21264641. medRxiv. 2021. Update in: Cell Rep Med. 2022 Mar 11;3(4):100583. doi: 10.1016/j.xcrm.2022.100583 PMID: 34642698 Free PMC article. Updated. Preprint.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Boucau J, et al. Among authors: uddin r. medRxiv [Preprint]. 2022 Mar 2:2022.03.01.22271582. doi: 10.1101/2022.03.01.22271582. medRxiv. 2022. Update in: N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092 PMID: 35262089 Free PMC article. Updated. Preprint.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews J, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Seaman MS, et al. Among authors: uddin r. medRxiv [Preprint]. 2022 Mar 3:2022.03.02.22271731. doi: 10.1101/2022.03.02.22271731. medRxiv. 2022. Update in: JCI Insight. 2022 Oct 10;7(19):e159944. doi: 10.1172/jci.insight.159944 PMID: 35262094 Free PMC article. Updated. Preprint.
The 2022 RSV surge was driven by multiple viral lineages.
Adams G, Moreno GK, Petros BA, Uddin R, Levine Z, Kotzen B, Messer K, Dobbins ST, DeRuff KC, Loreth C, Brock-Fisher T, Schaffner SF, Chaluvadi S, Kanjilal S, Luban J, Ozonoff A, Park D, Turbett S, Siddle KJ, MacInnis BL, Sabeti P, Lemieux J. Adams G, et al. Among authors: uddin r. medRxiv [Preprint]. 2023 Jan 5:2023.01.04.23284195. doi: 10.1101/2023.01.04.23284195. medRxiv. 2023. Update in: N Engl J Med. 2023 Apr 6;388(14):1335-1337. doi: 10.1056/NEJMc2216153 PMID: 36656774 Free PMC article. Updated. Preprint.
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy.
Edelstein GE, Boucau J, Uddin R, Marino C, Liew MY, Barry M, Choudhary MC, Gilbert RF, Reynolds Z, Li Y, Tien D, Sagar S, Vyas TD, Kawano Y, Sparks JA, Hammond SP, Wallace Z, Vyas JM, Barczak AK, Lemieux JE, Li JZ, Siedner MJ. Edelstein GE, et al. Among authors: uddin r. medRxiv [Preprint]. 2023 Jun 27:2023.06.23.23288598. doi: 10.1101/2023.06.23.23288598. medRxiv. 2023. Update in: Ann Intern Med. 2023 Dec;176(12):1577-1585. doi: 10.7326/M23-1756 PMID: 37425934 Free PMC article. Updated. Preprint.
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency.
Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Speidel T, Liew MY, Edelstein GE, Kawano Y, Uddin R, Deo R, Marino C, Getz MA, Reynold Z, Barry M, Gilbert RF, Tien D, Sagar S, Vyas TD, Flynn JP, Hammond SP, Novack LA, Choi B, Cernadas M, Wallace ZS, Sparks JA, Vyas JM, Seaman MS, Gaiha GD, Siedner MJ, Barczak AK, Lemieux JE, Li JZ. Li Y, et al. Among authors: uddin r. medRxiv [Preprint]. 2023 Aug 7:2023.07.31.23293441. doi: 10.1101/2023.07.31.23293441. medRxiv. 2023. Update in: Sci Transl Med. 2024 Jan 24;16(731):eadk1599. doi: 10.1126/scitranslmed.adk1599 PMID: 37577493 Free PMC article. Updated. Preprint.
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
Phan T, Ribeiro RM, Edelstein GE, Boucau J, Uddin R, Marino C, Liew MY, Barry M, Choudhary MC, Tien D, Su K, Reynolds Z, Li Y, Sagar S, Vyas TD, Kawano Y, Sparks JA, Hammond SP, Wallace Z, Vyas JM, Li JZ, Siedner MJ, Barczak AK, Lemieux JE, Perelson AS. Phan T, et al. Among authors: uddin r. bioRxiv [Preprint]. 2024 Sep 16:2024.09.13.613000. doi: 10.1101/2024.09.13.613000. bioRxiv. 2024. PMID: 39345409 Free PMC article. Preprint.
Physical activity and mental health: a systematic review and best-evidence synthesis of mediation and moderation studies.
White RL, Vella S, Biddle S, Sutcliffe J, Guagliano JM, Uddin R, Burgin A, Apostolopoulos M, Nguyen T, Young C, Taylor N, Lilley S, Teychenne M. White RL, et al. Among authors: uddin r. Int J Behav Nutr Phys Act. 2024 Nov 28;21(1):134. doi: 10.1186/s12966-024-01676-6. Int J Behav Nutr Phys Act. 2024. PMID: 39609855 Free PMC article. Review.
279 results